Antioestrogen vs antioestrogen
- Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome 2016 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 567 participantsGRADE not reported
It is very uncertain whether antioestrogen changes clomiphene citrate plus tamoxifen versus clomiphene citrate ‐… compared with antioestrogen (very low certainty).
Antioestrogen showed no clear difference in clomiphene citrate versus tamoxifen ‐ Live birth rate compared with antioestrogen (low certainty).
Antioestrogen showed no clear difference in clomiphene citrate versus tamoxifen ‐ Miscarriage rate compared with antioestrogen (low certainty).
It is very uncertain whether antioestrogen changes clomiphene citrate versus tamoxifen ‐ Multiple pregnancy compared with antioestrogen (very low certainty).
The LNG‐IUS with endometrial surveillance probably leads to lower endometrial polyps compared with endometrial surveillance alone (moderate certainty).
The LNG‐IUS with endometrial surveillance probably leads to lower endometrial hyperplasia compared with endometrial surveillance alone (moderate certainty).
The LNG‐IUS with endometrial surveillance showed no clear difference in fibroids compared with endometrial surveillance alone (moderate certainty).
The LNG‐IUS with endometrial surveillance probably leads to higher abnormal vaginal bleeding or spotting compared with endometrial surveillance alone (moderate certainty).
The LNG‐IUS with endometrial surveillance showed no clear difference in breast cancer recurrence compared with endometrial surveillance alone (moderate certainty).
The LNG‐IUS with endometrial surveillance showed no clear difference in breast cancer‐related death compared with endometrial surveillance alone (moderate certainty).